search
Back to results

Assessment of Visual and Refractive Results and Rotational Stability of the TECNIS® Eyhance Toric II 1-piece Posterior Chamber Lens in Patients With Astigmatism Undergoing Cataract Surgery (STATE)

Primary Purpose

Cataract, Astigmatism

Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Images of the operated eye (s)
Sponsored by
Fondation Ophtalmologique Adolphe de Rothschild
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cataract focused on measuring TECNIS® Eyhance Toric II 1-piece posterior chamber lens

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion criteria

  • Aged ≥ 18 years
  • Patients scheduled for bilateral cataract surgery
  • For at least one eye :

    • Cataract surgery clinically indicated
    • Corneal astigmatism ≥ 1 D
    • Planned cataract surgery with placement of a TECNIS® Eyhance Toric II 1-piece posterior chamber lens

Non inclusion criteria

  • Pregnant or breast-feeding women
  • In the eye with planned cataract surgery with placement of a TECNIS® Eyhance Toric II 1-piece posterior chamber lens:

    • Irregular astigmatism (keratoconus suspicion)
    • Corneal scaring in visual axis
    • Retinal impairment that may limit visual recovery (macular degeneration, history of retinal detachment, etc.)
    • Visually impaired eye since childhood that cannot be improved despite correction of the refractive disorder
    • Any other ophthalmic disease inducing visual impairment

Sites / Locations

  • Hôpital Fondation A. de Rothschuld

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Patients operated with a TECNIS® Eyhance Toric II 1-piece posterior chamber lens

Arm Description

For at least one eye : Planned cataract surgery with placement of a TECNIS® Eyhance Toric II 1-piece posterior chamber lens

Outcomes

Primary Outcome Measures

The mean of the best monocular uncorrected distance visual acuity UDVA (logMAR) at 1 month post-operative
The mean of the best monocular corrected distance visual acuity (CDVA) (logMAR) preoperative (maximum 12 months before surgery)

Secondary Outcome Measures

Full Information

First Posted
November 10, 2021
Last Updated
October 18, 2023
Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Collaborators
Johnson & Johnson
search

1. Study Identification

Unique Protocol Identification Number
NCT05144308
Brief Title
Assessment of Visual and Refractive Results and Rotational Stability of the TECNIS® Eyhance Toric II 1-piece Posterior Chamber Lens in Patients With Astigmatism Undergoing Cataract Surgery
Acronym
STATE
Official Title
Assessment of Visual and Refractive Results, and Rotational Stability of the TECNIS® Eyhance Toric II 1-piece Posterior Chamber Lens in Patients With Astigmatism Undergoing Cataract Surgery: a Prospective Cohort Study - STATE
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Terminated
Why Stopped
Sponsor-investigator agreement
Study Start Date
December 7, 2021 (Actual)
Primary Completion Date
June 22, 2023 (Actual)
Study Completion Date
October 9, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Collaborators
Johnson & Johnson

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Cataract surgery is one of the most common procedures performed worldwide. Astigmatism is the most common refractive disorder in adults, hence there is a high prevalence of preexisting astigmatism in cataract patients. Access to astigmatism correction during cataract surgery allows for improved visual outcomes for patients. Toric intraocular lenses (IOLs) are the procedure of choice to correct corneal astigmatism of one diopter or more in cases undergoing cataract surgery. Rotational stability is a key factor for successful outcomes with toric IOLs. Postoperative toric IOL misalignment is the major factor responsible for suboptimal visual outcomes after toric IOL implantation. The TECNIS® Eyhance Toric II 1-piece posterior chamber lens is a new toric IOL which is FDA approved and CE marked. Marketed by Johnson & Johnson Vision, it is indicated for the visual correction of aphakia and pre-existing corneal astigmatism of one diopter or greater in adult patients with or without presbyopia in whom a cataractous lens has been removed by phacoemulsification and who desire reduction in residual refractive cylinder. No study assessing the early rotational stability of the TECNIS® Eyhance Toric II IOL has been published yet.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract, Astigmatism
Keywords
TECNIS® Eyhance Toric II 1-piece posterior chamber lens

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
Single-center prospective cohort study
Masking
None (Open Label)
Allocation
N/A
Enrollment
13 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Patients operated with a TECNIS® Eyhance Toric II 1-piece posterior chamber lens
Arm Type
Experimental
Arm Description
For at least one eye : Planned cataract surgery with placement of a TECNIS® Eyhance Toric II 1-piece posterior chamber lens
Intervention Type
Procedure
Intervention Name(s)
Images of the operated eye (s)
Intervention Description
Through the operating microscope or a slit lamp, dilated pupil. Taken on the day of surgery (D0) and at 1 week, 1 month and 3 months post-op
Primary Outcome Measure Information:
Title
The mean of the best monocular uncorrected distance visual acuity UDVA (logMAR) at 1 month post-operative
Time Frame
1 month
Title
The mean of the best monocular corrected distance visual acuity (CDVA) (logMAR) preoperative (maximum 12 months before surgery)
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria Aged ≥ 18 years Patients scheduled for bilateral cataract surgery For at least one eye : Cataract surgery clinically indicated Corneal astigmatism ≥ 1 D Planned cataract surgery with placement of a TECNIS® Eyhance Toric II 1-piece posterior chamber lens Non inclusion criteria Pregnant or breast-feeding women In the eye with planned cataract surgery with placement of a TECNIS® Eyhance Toric II 1-piece posterior chamber lens: Irregular astigmatism (keratoconus suspicion) Corneal scaring in visual axis Retinal impairment that may limit visual recovery (macular degeneration, history of retinal detachment, etc.) Visually impaired eye since childhood that cannot be improved despite correction of the refractive disorder Any other ophthalmic disease inducing visual impairment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jean-Luc FEBBRARO, MD
Organizational Affiliation
Hôpital Fondation A. de Rothschild
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hôpital Fondation A. de Rothschuld
City
Paris
State/Province
Hôpital Fondation A. De Rothschild
ZIP/Postal Code
75019
Country
France

12. IPD Sharing Statement

Learn more about this trial

Assessment of Visual and Refractive Results and Rotational Stability of the TECNIS® Eyhance Toric II 1-piece Posterior Chamber Lens in Patients With Astigmatism Undergoing Cataract Surgery

We'll reach out to this number within 24 hrs